about
Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling.Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease.Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis.Serum amyloid A in uremic HDL promotes inflammationEffect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysisThe natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolPeriodontal disease: a covert source of inflammation in chronic kidney disease patients.Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiographySoluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results.Prevalence and management of chronic kidney disease in primary care patients in the UK.Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology.Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease.Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum.Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.Amount and pattern of physical activity and sedentary behavior are associated with kidney function and kidney damage: The Maastricht Study.
P2860
Q34607582-06A16DC6-DBB5-431B-83E5-830758217FC8Q34887167-708AFD4E-F240-44CB-848C-EF73FDB3106AQ35753157-22CD93C8-1444-42D0-A9F6-4EBA56A17EE3Q35917487-78F5F9F8-C902-44AF-B08C-561CB6C28381Q36127484-74044A75-2DCC-4135-A0E5-870FAF0265D7Q36875566-346CACA0-CFC8-4ACF-947F-6C754C8BD296Q36948512-41A8BF80-4984-48DD-8022-07A5F2AEC200Q37042084-4131D850-EC3A-4A0E-BC28-EBA803CEAEFFQ37078155-EA36A4D6-C9B1-4E70-B7C9-4D2F5534870EQ37415728-A6AFAEF3-EF1A-4AF7-A83A-2E7AEAED9FA0Q37871569-2C09C258-4321-44E0-8122-1608F9530BD3Q38032025-F647F22D-B4CB-4697-9EDA-840123137381Q43887329-27F0255D-573B-48C1-9F24-EB5ABD504C37Q44350038-EB8275EB-33C2-40C6-9DBB-E5D09ED8922EQ45018908-A81F4973-1061-42CC-9812-8EAA8C0EA2BFQ48127961-724478BF-393B-44C9-984C-3799A54BC9E5Q48181150-95C1337D-EAD6-4621-AFDF-E3B4C3F6E029Q50300037-CEDD8D40-0A52-4D48-8971-B5440105B6B3Q52673652-FE167149-5D67-4186-ACE8-241A026F81AFQ55439397-3F1C5265-CDB1-492C-9675-83A69D021E2E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Kidney disease and cardiovascular risk.
@ast
Kidney disease and cardiovascular risk.
@en
type
label
Kidney disease and cardiovascular risk.
@ast
Kidney disease and cardiovascular risk.
@en
prefLabel
Kidney disease and cardiovascular risk.
@ast
Kidney disease and cardiovascular risk.
@en
P1476
Kidney disease and cardiovascular risk.
@en
P2093
Marc A Pfeffer
P304
P356
10.1146/ANNUREV.MED.58.071105.111123
P577
2007-01-01T00:00:00Z